Colombia vs Gambia: Cause of death, by non-communicable diseases, ages 15-59
Colombia
33.6%
in 2021
Gambia
36.3%
in 2021
Colombia rank
167th
Gambia rank
164th
Cause of death, by non-communicable diseases, ages 15-59 over time
- Colombia
- Gambia
How they compare
Gambia currently reports 36.3% against 33.6% in Colombia, a difference of 2.7%.
That makes Gambia's figure about 1.1 times Colombia's.
The two have swapped places 2 times across 6 shared years of data; in 2000 it was Gambia ahead.
Colombia ranks 167th and Gambia ranks 164th of 185 countries.
Across the 3 decades both report, Colombia averaged higher in 2 and Gambia in 1.
Head to head by decade
| Decade | Colombia | Gambia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 31.6% | 35.4% | 3.7% | Gambia |
| 2010s | 44.2% | 37.4% | 6.8% | Colombia |
| 2020s | 37.7% | 37.6% | 0.1% | Colombia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, Colombia or Gambia?
- Gambia, at 36.3% against 33.6% in Colombia as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59 between Colombia and Gambia?
- 2.7%, with Gambia ahead.
- How many years of comparable data are there for Colombia and Gambia?
- 6 years are reported by both, from 2000 to 2021.
- How do Colombia and Gambia rank globally for cause of death, by non-communicable diseases, ages 15-59?
- Colombia ranks 167th and Gambia ranks 164th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59 (% of total deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths ages 15-59 due to non-communicable diseases divided by number of all deaths ages 15-59 expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.